Anika Therapeutics Inc. (ANIK): Price and Financial Metrics
GET POWR RATINGS... FREE!
ANIK POWR Grades
- ANIK scores best on the Value dimension, with a Value rank ahead of 76.65% of US stocks.
- The strongest trend for ANIK is in Growth, which has been heading up over the past 177 days.
- ANIK's current lowest rank is in the Sentiment metric (where it is better than 21.08% of US stocks).
ANIK Stock Summary
- The price/operating cash flow metric for ANIKA THERAPEUTICS INC is higher than 91.6% of stocks in our set with a positive cash flow.
- ANIK's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 14.35% of US stocks.
- Over the past twelve months, ANIK has reported earnings growth of 246.98%, putting it ahead of 93.44% of US stocks in our set.
- Stocks that are quantitatively similar to ANIK, based on their financial statements, market capitalization, and price volatility, are FORG, RCEL, DDD, FLYW, and WEAV.
- ANIK's SEC filings can be seen here. And to visit ANIKA THERAPEUTICS INC's official web site, go to www.anikatherapeutics.com.
ANIK Valuation Summary
- ANIK's EV/EBIT ratio is -18.3; this is 284.85% lower than that of the median Healthcare stock.
- ANIK's price/sales ratio has moved up 2.2 over the prior 243 months.
Below are key valuation metrics over time for ANIK.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
ANIK | 2023-01-20 | 3.0 | 1.6 | -28.7 | -18.3 |
ANIK | 2023-01-19 | 2.9 | 1.6 | -28.2 | -17.9 |
ANIK | 2023-01-18 | 2.9 | 1.6 | -28.3 | -18.0 |
ANIK | 2023-01-17 | 3.0 | 1.6 | -28.9 | -18.4 |
ANIK | 2023-01-13 | 3.0 | 1.6 | -28.8 | -18.4 |
ANIK | 2023-01-12 | 3.0 | 1.6 | -28.9 | -18.4 |
ANIK Growth Metrics
- Its 2 year cash and equivalents growth rate is now at 37.2%.
- Its 5 year revenue growth rate is now at 19.91%.
- The year over year net income to common stockholders growth rate now stands at 93.92%.

The table below shows ANIK's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 152.435 | 8.4 | -15.744 |
2022-06-30 | 151.707 | 7.753 | -11.011 |
2022-03-31 | 150.195 | 8.959 | -1.637 |
2021-12-31 | 147.794 | 8.397 | 4.134 |
2021-09-30 | 144.661 | 6.512 | -5.729 |
2021-06-30 | 136.819 | 10.315 | -12.698 |
ANIK's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- ANIK has a Quality Grade of B, ranking ahead of 75.55% of graded US stocks.
- ANIK's asset turnover comes in at 0.363 -- ranking 122nd of 186 Medical Equipment stocks.
- SYK, EYE, and ISRG are the stocks whose asset turnover ratios are most correlated with ANIK.
The table below shows ANIK's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.363 | 0.555 | -0.097 |
2021-03-31 | 0.326 | 0.532 | -0.187 |
2020-12-31 | 0.322 | 0.529 | -0.144 |
2020-12-31 | 0.322 | 0.529 | -0.144 |
2020-09-30 | 0.322 | 0.576 | -0.027 |
2020-06-30 | 0.337 | 0.636 | 0.076 |
ANIK Price Target
For more insight on analysts targets of ANIK, see our ANIK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $49.67 | Average Broker Recommendation | 1.33 (Strong Buy) |
ANIK Stock Price Chart Interactive Chart >
ANIK Price/Volume Stats
Current price | $30.07 | 52-week high | $33.18 |
Prev. close | $30.66 | 52-week low | $19.95 |
Day low | $30.03 | Volume | 66,405 |
Day high | $30.76 | Avg. volume | 72,279 |
50-day MA | $30.15 | Dividend yield | N/A |
200-day MA | $25.16 | Market Cap | 439.32M |
Anika Therapeutics Inc. (ANIK) Company Bio
Anika Therapeutics develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. The company was founded in 1983 and is based in Bedford, Massachusetts.
Latest ANIK News From Around the Web
Below are the latest news stories about ANIKA THERAPEUTICS INC that investors may wish to consider to help them evaluate ANIK as an investment opportunity.
Is Anika Therapeutics (ANIK) Stock Outpacing Its Medical Peers This Year?Here is how Anika Therapeutics (ANIK) and Achilles Therapeutics PLC Sponsored ADR (ACHL) have performed compared to their sector so far this year. |
Biogen (BIIB), Eisai's Lecanemab Gets FDA Nod for Alzheimer'sFDA approves Biogen (BIIB) and Eisai's lecanemab on an accelerated basis. Eisai filed a supplemental biologics license application (sBLA) to the FDA to get a traditional approval for Leqembi. |
Multiple insiders bought Anika Therapeutics, Inc. (NASDAQ:ANIK) stock earlier this year, a positive sign for shareholdersIt is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it... |
Medical Aesthetics Global Market Report 2022: Ukraine-Russia War ImpactNEW YORK, Dec. 12, 2022 /PRNewswire/ -- AbbVie Inc, Medytox Inc, Galderma S. A., Alma Lasers Ltd, Merz Pharma GmbH and Co KGaA, Cynosure LLC, Fotona d.o.o., Anika Therapeutics Inc., Johnson & Johnson, Cutera Inc, Solta Medical International Inc, Quanta System SpA, Sisram Medical Ltd.,… |
Companies - Anika Therapeutics, Inc. Expected to Post FY2022 Earnings of Per ShareAnika Therapeutics, Inc. - Barrington Research upped their FY2022 earnings per share estimates for shares of Anika Therapeutics in a report released on Wednesday, November 9th… |
ANIK Price Returns
1-mo | 1.59% |
3-mo | 0.13% |
6-mo | 21.84% |
1-year | -3.96% |
3-year | -26.85% |
5-year | -54.93% |
YTD | 1.59% |
2022 | -17.39% |
2021 | -20.84% |
2020 | -12.71% |
2019 | 54.27% |
2018 | -37.66% |
Continue Researching ANIK
Here are a few links from around the web to help you further your research on Anika Therapeutics Inc's stock as an investment opportunity:Anika Therapeutics Inc (ANIK) Stock Price | Nasdaq
Anika Therapeutics Inc (ANIK) Stock Quote, History and News - Yahoo Finance
Anika Therapeutics Inc (ANIK) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...